HIGH EXPRESSION OF BCL-2 PREDICTS POOR OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH CHOP-BASED CHEMOTHERAPY

被引：0
|
作者：
Lee, H. W. [1 ]
Choi, J. -H. [1 ]
Ahn, M. S. [1 ]
Kang, S. Y. [1 ]
Jeong, S. H. [1 ]
Park, J. S. [1 ]
Han, J. H. [2 ]
Kim, J. H. [2 ]
机构：
[1] Ajou Univ Hosp, Dept Hematol Oncol, Suwon, South Korea
[2] Ajou Univ Hosp, Dept Pathol, Suwon, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [41] Bcl-2 protein in diffuse large B-cell lymphoma Response
    Hallack Neto, Abrahao Elias
    Coelho Siqueira, Sheila Aparecida
    Dulley, Frederico Luiz
    Chauobah, Alfredo
    Belesso, Marcelo
    Saboia, Rosaura
    Ruiz, Milton Artur
    Fischer Chamone, Dalton Alencar
    Pereira, Juliana
    SAO PAULO MEDICAL JOURNAL, 2011, 129 (01): : 54 - 54
  • [42] BCL-Xl Expression Is Druggable Biomarker Associated with a Poor Clinical Outcome in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
    Gu, Juan J.
    Vacaro, Michael
    Attwood, Kris
    Mavis, Cory
    Torka, Pallawi
    Barth, Matthew J.
    Hernandez-Ilizaliturri, Francisco J.
    BLOOD, 2019, 134
  • [43] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Hui, D.
    Proctor, B.
    Donaldson, J.
    Shenkier, T.
    Hoskins, P.
    Klasa, R.
    Savage, K.
    Gascoyne, R.
    Connors, J. M.
    Sehn, L. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 186 - 187
  • [44] Bcl-2 protein frequency in patients with high-risk diffuse large B-cell lymphoma
    Hallack Neto, Abrahao Elias
    Coelho Siqueira, Sheila Aparecida
    Dulley, Frederico Luiz
    Chauobah, Alfredo
    Belesso, Marcelo
    Saboia, Rosaura
    Ruiz, Milton Artur
    Fischer Chamone, Dalton Alencar
    Pereira, Juliana
    SAO PAULO MEDICAL JOURNAL, 2010, 128 (01): : 14 - 17
  • [45] Prognostic significance of primary extranodal diffuse large B-cell lymphoma (DLBCL) in patients treated with R-CHOP
    Proctor, B. R.
    Hui, D.
    Donaldson, J.
    Savage, K. J.
    Shenkier, T. N.
    Hoskins, P. J.
    Klasa, R.
    Randy, G.
    Joseph, C.
    Sehn, L. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab
    Kurokawa, Toshiro
    Hase, Makiko
    Tokuman, Naoko
    Yoshida, Takashi
    HEMATOLOGICAL ONCOLOGY, 2011, 29 (01) : 5 - 9
  • [47] High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
    Berglund, Mattias
    Hedstrom, Gustav
    Amini, Rose-Marie
    Enblad, Gunilla
    Thunberg, Ulf
    ONCOLOGY REPORTS, 2013, 29 (02) : 720 - 724
  • [48] BCL-2, BCL-6 AND MYC REARRANGEMENTS AND CLINICAL OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA
    Sobas, M. S.
    Tojo, M.
    Tubio, M.
    Fraga, M.
    Bello, J. L.
    Forteza, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 278 - 279
  • [49] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    BLOOD, 2013, 121 (12) : 2253 - 2263
  • [50] Extra copy number of BCL2 is correlated with increased BCL-2 protein expression and poor survival in diffuse large B-cell lymphoma treated with chemoimmunotherapy
    Hwang, Hee Sang
    Sung, Hyun-Jung
    Kim, Mee-Jeong
    Yoon, Dok Hyun
    Park, Chan-Sik
    Huh, Jooryung
    Go, Heounjeong
    LEUKEMIA & LYMPHOMA, 2022, 63 (13) : 3072 - 3081
12345